Purpose of Review <p>To summarize the features and management of asbestos related lung disease while highlighting some potential challenges that may be faced by healthcare providers when managing this heterogenous group of disease in the elderly.</p> Recent Findings <p>Immunotherapy is effective in improving survival rates in patients with mesothelioma and asbestos related lung cancer; however, the elderly are currently under represented in clinical trials making it challenging for clinicians to possibly decide optimal treatment for this group of patients. Compensation claims for mesothelioma associated with occupational exposure is lower in older patients suggesting that awareness is low in this cohort.</p> Summary <p>The geriatric population is a unique group of patients that present with unique challenges such as co-existing multi-morbidities, polypharmacy, frailty, and psychosocial/ social-economic issues. A more holistic approach including comprehensive frailty assessment is needed when managing this group of patients especially in asbestos associated malignant disorders.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Dust from the Past: Asbestos Related Lung Disease, a Disease of the Elderly

  • Adeline Tan,
  • Lorraine Thong

摘要

Purpose of Review

To summarize the features and management of asbestos related lung disease while highlighting some potential challenges that may be faced by healthcare providers when managing this heterogenous group of disease in the elderly.

Recent Findings

Immunotherapy is effective in improving survival rates in patients with mesothelioma and asbestos related lung cancer; however, the elderly are currently under represented in clinical trials making it challenging for clinicians to possibly decide optimal treatment for this group of patients. Compensation claims for mesothelioma associated with occupational exposure is lower in older patients suggesting that awareness is low in this cohort.

Summary

The geriatric population is a unique group of patients that present with unique challenges such as co-existing multi-morbidities, polypharmacy, frailty, and psychosocial/ social-economic issues. A more holistic approach including comprehensive frailty assessment is needed when managing this group of patients especially in asbestos associated malignant disorders.